Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVP-6124 extension study in schizophrenia
NCT01714713Phase 3Completed
- Sponsor
- FORUM Pharmaceuticals
- Start
- Jun 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of encenicline in schizophrenia, sponsored by FORUM Pharmaceuticals. Started Jun 2013; status: completed.
02
Drugs
encenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01714713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714713.